göran olivecrona, md, phd department of cardiology lund university

22
Göran Olivecrona, MD, Phd Department of Cardiology Lund University Skåne University Hospital, Sweden patients: patients: Results from the RAPID MI-ICE Results from the RAPID MI-ICE trial and insights to the trial and insights to the CHILL MI trial: CHILL MI trial: Why Hypothermia is Why Hypothermia is Cool Cool again again 2011 2011

Upload: dorian-graves

Post on 13-Mar-2016

38 views

Category:

Documents


0 download

DESCRIPTION

Hypothermia in awake STEMI patients: Results from the RAPID MI-ICE trial and insights to the CHILL MI trial: Why Hypothermia is Cool again. Göran Olivecrona, MD, Phd Department of Cardiology Lund University Skåne University Hospital , Sweden. 2011. Potential conflicts of interest. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Göran Olivecrona, MD, PhdDepartment of CardiologyLund UniversitySkåne University Hospital, Sweden

Hypothermia in awake STEMI patients:Hypothermia in awake STEMI patients:Results from the RAPID MI-ICE trial Results from the RAPID MI-ICE trial and insights to the CHILL MI trial:and insights to the CHILL MI trial:

Why Hypothermia is Why Hypothermia is CoolCool again again

20112011

Page 2: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Speaker’s name: Göran Olivecrona

I have the following potential conflicts of interest to report: Other(s)

Unrestricted Grant, Innercool, Inc, San Diego, CA

Minor Lectur honorariums

Potential conflicts of interest

Jolife AB, Medtronic,Abbott VascularCordis,Physio ControlTerumoEdwards Lifesciences

Page 3: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Treatment of Myocardial infarction:Revascularisation

• Thrombolysis • Primary-PCI

Page 4: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Background hypothermia for the heart

• Hypothermia protects the heart during:

Cardiac surgery Heart transplantations

Page 5: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Hypothermia in the prevention of MI Animal studies

Control

xxx

Open surgery ligation of LAD in pigs. 34 C during 40 out of 60 min ischemia (Radiant).

Hypothermia

Ischemia 60 minHypothermia 55 min

Start after 20 min ischemia

End 15 minafter

reperfusionSlow warm up

2 h

80% relative reduction in infarct size (P < 0.001)

Based on this study on 22 animals two major clinical trials were conducted

Reperfusion 3 h.

Dae MW, et al. 2002, Am J Physiol Heart Circ Physiol

Page 6: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Reperfusion injury

Reperfusion

Infarctionsize

Time

Ischemia

Page 7: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Mechanism of Cardioprotection

• Cyclosporin: Mitocondria• C5a inhib: Complement• Adenosine: Inflammation• Postcond: Myocyte(?)• PKCdelta-: Myocyte apoptosis• ?: Metabolism• ?: Reactive hyperemia• ?: Endothelium• ?: Systemic effects

Hypothermia

Page 8: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Hypothermia for MI

• Two failed larger clinical studies COOL MI COOL MI ICE ITICE IT

• Failed because only 1/3 randomized to Hypothermia reached <35°C at time of Reperfusion ?

Page 9: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Hypothermia for MI

• Is target temp <35°C the key?• How can that be achieved?• How can we cool the awake patient?

More basic animal research needed

Page 10: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Hypothermia protocol for rapid cooling

Celsius Control System™Endovascular cooling catheter (14 F)Initiation and maintaining hypothermia

1000 ml cold saline (4ºC)Quick initiation of hypothermia

Combination hypothermia: Cold saline (4ºC), 1000 ml iv infusion in 5 min as a ”kick start” for quick initiation of hypothermia together with an endovascular cooling catheter.

Page 11: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Infarct size/area at risk(Porcine model)

Gotberg et al., BMC Cardiovascular Disorders, 2008

~ 5 min to reach < 35ºC with cold saline and endovascular cooling

Pre-reperfusion cooling reduce infarct size.Post-reperfusion cooling has no effect

39% reduction

Page 12: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Speckled infarction in pigWavefront phenomenon

(Jennings)Hypothermia Normothermia

Hypothermia causes disruption of the wavefront phenomenon.Götberg M et al . BMC Cardiovasc Disord. 2008, 8:7

Also seen in hypothermia treatment by Dae et al., Am J Physiol, 2002, with SPECT

Page 13: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

RAPID MI-ICEThe Rapid Intravascular Cooling in Myocardial Infarction as Adjunctive to Percutaneous Coronary Intervention

study

(Safety & Feasibility study in man)

• 20 Patients• Anterior or large Inferior STEMI• <6 hrs from onset of symtoms• Rapid infusion 1-2 liters 4°C Saline solution.• Endovascular cooling with Philips InnerCool endovascular system with Accutrol catheter starting before angiogram and continuing 3 h after PCI• Cardiac MRI day 4±2, infarct size/ myocardium at risk (T2 stir)

Primary outcome: Safety and FeasibilitySecondary outcome: Reduction in infarct size Gotberg et al. Circ Cardiovasc Interv. 2010 Oct;3(5):400-7.

Page 14: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Feasibility

Arrival at cath lab

0 10 20 30 40 50 60 7033

34

35

36

37

HypothermiaControl

Time (min)

Tem

pera

ture

(C)

ECG Patient Info

Randomization

Time ofreperfusion

Initiation of cold saline

infusion

Initiation ofendovascular

cooling

Patient prep, catheterization Angiography, PCI

End of PCI

14 ± 5 min 14 ± 6 min 15 ± 3 min40 ± 6 min

HypothermiaControl

3 min prolonged procedure before reperfusion

Temp: 34.7 ± 0.3°C at reperfusion

All patients reached target temp

Gotberg et al. Circ Cardiovasc Interv. 2010 Oct;3(5):400-7.

Page 15: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Clinical and Angiographic Data Variable Hypothermia (n=9) Control (n=9)Age 62 ± 10 58 ± 7 NS Women 2 2 NSHypertension 3 2 NSDiabetes 1 2 NSInfarct related artery  LAD 6 7 NS

RCA 3 2 NSInitial TIMI flow  0/1 7 8 NS

2/3 2 1 NSOnset of symptoms 174 ± 51 174 ± 62 NSto reperfusion (min)Door-to-balloon time (min) 43 ± 7 40 ± 6 NS

Successful revascularization 9 9 NSTIMI 3 flow post PCI 9 9 NSThrombectomy 8 7 NSAbciximab 6 6 NSBivalirudin 3 3 NS

2/20 patients, One from each group was excluded for technical reasonsGotberg et al. Circ Cardiovasc Interv. 2010 Oct;3(5):400-7.

Page 16: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Variable Hypothermia Control (n=9) (n=9)

30 day mortality 0 0Re-infarction 0 0 CABG 0 030 day MACE 0 0 Heart failure 0 3 VT/VF 0 2 Stroke 0 0 Infection 3 0 Major bleeding 0 0 Bradycardia 0 0

Safety

NT-proBNP day 1

Hypothermia Control0

500

1000

1500

2000

NT-

proB

NP

(ng/

l)

Gotberg et al. Circ Cardiovasc Interv. 2010 Oct;3(5):400-7.

Page 17: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Reduction of infarct size Final Infarct Size/ Myocardium at Risk

Reduction in Troponin (Peak value)

Efficacy

p = 0·04

Hypothermia Control0

1020304050607080

Δ = 38%

Infa

rct s

ize

/ Myo

card

ium

at r

isk

Hypothermia Control012345678

Trop

onin

T (u

g/l)

p = 0·01Δ = 43%

Gotberg et al. Circ Cardiovasc Interv. 2010 Oct;3(5):400-7.

Page 18: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Speckled infarction in man

Gotberg et al. Circ Cardiovasc Interv. 2010 Oct;3(5):400-7.

Page 19: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

CHILL-MIRapid Endovascular Catheter Core Cooling combined with cold saline as an Adjunct to Percutaneous Coronary Intervention For the

Treatment of Acute Myocardial InfarctionA Randomized, Controlled Study of the Use of Central Venous

Catheter Core Cooling combined with cold saline as an Adjunct to Percutaneous Coronary Intervention For the Treatment of Acute

Myocardial Infarction

Principal InvestigatorsDavid Erlinge and Göran Olivcecrona

http://clinicaltrials.gov/ct2/show/NCT01379261?term=olivecrona&rank=1

Page 20: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

ProtocolPatients will receive 1-2 liters of cold (4° C) saline solution upon arrival to cath lab, together with buspirone and meperidine.

Endovascular cooling will begin prior to diagnostic angiography and PCI.

After first reperfusion, cooling will be maintained for 1 hour. Then the cooling catheter will be removed and the patient will spontaneously rewarm at CCU.

120 patients at 10 sites in Europe

Page 21: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Endpoint

Primary Efficacy Endpoint:

Cardiac MRI infarct size as a percentage of area at risk at 4±2 days. (MRI)

Page 22: Göran Olivecrona, MD, Phd Department of Cardiology Lund University

Conclusions

• Troponin T release was significantly reduced.

• Rapid induction of hypothermia with iv cold saline and endovascular catheter reduces Infarct size by 38% in animals and 39% in humans (infarct size/ area at risk).

• Hypothermia treated animals and humans exhibit a morphologically “different” infarkt (Speckled infarct) as opposed to the wave front Phenomenon.• All patients in RAPID MI-ICE reached target temperature, <35°C, before reperfusion.

• A larger trial to verify findings from animal research and RAPID MI-ICE is needed: CHILL-MI (Start June 2011)